CD28 and COVID-19: Upon in vitro stimulation with anti-CD3/CD28 antibodies, CD4 T cells of COVID-19 patients showed a lower capacity to express IFNγ and IL-2 and proliferated together with the number of CFSElow cells (a measure of T-cell proliferation) compared to similar T-cell subsets of the control group [21].